Although animal experiments supported the effect of hyaluronic acid (HA)-modified liposomes on the delivery of chemotherapeutic agents to cancer cells with high CD44 expression, research on targeted therapy and immunotherapy is lacking [142]. This evidence concerns the gene CD44 and cancer.